首页> 外文OA文献 >EFFECTIVENESS AND COST-EFFECTIVENESS OF HAEMODIALYSIS (HD) AND PERITONEAL DIALYSIS (PD) FOR PATIENTS WITH END-STAGE RENAL DISEASE (ESRD) IN SINGAPORE

【2h】

EFFECTIVENESS AND COST-EFFECTIVENESS OF HAEMODIALYSIS (HD) AND PERITONEAL DIALYSIS (PD) FOR PATIENTS WITH END-STAGE RENAL DISEASE (ESRD) IN SINGAPORE

机译：终末期肾病（ESRD）患者的血液透析（HD）和腹膜透析（PD）的疗效和成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
YANG FAN;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore [J] . Yang Fan, Lau Titus, Luo Nan Nephrology. . 2016,第8期

机译：血液透析和腹膜透析对终末期肾脏疾病患者的成本效益
2. ECONOMIC EVALUATION OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) AND HEMODIALYSIS (HD) FOR END-STAGE RENAL DISEASE (ESRD) PATIENTS IN INDONESIA [J] . Nugraha R. R., Thabrany H., Putri S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：对印度尼西亚末期肾病（ESRD）患者的连续动态腹膜透析（CAPAT）和血液透析（HD）的经济评价
3. ECONOMIC EVALUATION OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) AND HEMODIALYSIS (HD) FOR END-STAGE RENAL DISEASE (ESRD) PATIENTS IN INDONESIA [J] . Nugraha R. R., Thabrany H., Putri S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：对印度尼西亚末期肾病（ESRD）患者的连续动态腹膜透析（CAPAT）和血液透析（HD）的经济评价
4. Examining alternative End-Stage Renal Disease (ESRD) therapies through simulation [C] . Stephen D. Roberts, Thomas L. Gross, Douglas R. Maxwell Annual symposium on Simulation;Symposium on Simulation . 1979

机译：通过模拟检查替代性终末期肾脏疾病（ESRD）疗法
5. The Effectiveness of an Evidence-based Continuous Ambulatory Peritoneal Dialysis (CAPD) Retraining Program to Reduce Peritonitis among Incident CAPD Patients [D] . Leung, Wai Yin. 2019

机译：基于证据的连续动态腹膜透析（CAPD）再培训计划的有效性降低了事件CAPD患者的腹膜炎
6. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy [O] . Carlos K. H. Wong, Julie Chen, Samuel K. S. Fung, 2020

机译：腹膜透析优先政策对终末期肾脏病患者一线透析方式的终生成本效益分析
7. FP604PERITONEAL DIALYSIS (PD) IN END-STAGE RENAL DISEASE PATIENTS (ESRD) WITH LIVER CIRRHOSIS: ONE CENTER EXPERIENCE [O] . Victor Burguera Vion, R Haridian Sosa Barrios, Melissa Cintra Cabrera, 2019

机译：FP604Peritoineal透析（PD）在末期肾病患者（ESRD）与肝硬化：一个中心经验
8. Laboratory Tests for the Management of End-Stage Renal Disease (ESRD) Dialysis Patients [R] . Handelsman, H. , Carter, E. 1986

机译：终末期肾病（EsRD）透析患者的实验室测试

EFFECTIVENESS AND COST-EFFECTIVENESS OF HAEMODIALYSIS (HD) AND PERITONEAL DIALYSIS (PD) FOR PATIENTS WITH END-STAGE RENAL DISEASE (ESRD) IN SINGAPORE

著录项

引文网络

相似文献

相关主题

期刊订阅